BATIRAXCEPT
UNII B6840JH4EB

Substance Identification & Data

This profile provides standardized clinical and technical data for Batiraxcept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) B6840JH4EB.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2268717-61-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

B6840JH4EB

CAS Registry Number

2268717-61-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

BATIRAXCEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C156017

National Cancer Institute reference terminology for clinical and research data.

INN ID

11391

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-227

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Batiraxcept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BATIRAXCEPT

Common Names & Synonyms

8-202-TYROSINE-PROTEIN KINASE RECEPTOR UFO (14-SERINE,54-VALINE,69-GLYCINE,74-ALANINE,109-ARGININE) (HUMAN) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN G1 (HUMAN .GAMMA.1-CHAIN C REGION C-TERMINAL FRAGMENT), DIMER

AXL FC FUSION PROTEIN AVB-S6-500

BATIRAXCEPT [INN]

BATIRAXCEPT [USAN]

BATIRAXCEPT [WHO-DD]

HUMAN TYROSINE-PROTEIN KINASE RECEPTOR UFO (AXL ONCOGENE, EC=2.7.10.1) (8-202) MODIFIED FRAGMENT (G14>S(7), A54>V(47), D69>G(62), V74>A(67), G109>R(102)) (1-195) FUSION PROTEIN WITH TETRAGLYCYLSERYL LINKER (196-200) FUSION PROTEIN WITH IGHG1*03 FC MODIFIED FRAGMENT ((HINGE DEL-(1-5)>(201-210)), CH3(K107>DEL(427))) (201-426),DIMER (206-206':209-209')-BISDISULFIDE, PRODUCED IN CHO CELL, GLYCOFORM ALFA